{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:26:42Z","timestamp":1762104402407,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jcjo.2022.12.009","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T23:40:31Z","timestamp":1673739631000},"page":"e166-e168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative management of high-risk corneal transplantation using basiliximab and mycophenolate mofetil"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-5701","authenticated-orcid":false,"given":"Cameron B.","family":"Reinisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7546-2769","authenticated-orcid":false,"given":"Asma M.","family":"Azam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5546-6017","authenticated-orcid":false,"given":"Albert Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-0967","authenticated-orcid":false,"given":"Amit","family":"Govil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-3172","authenticated-orcid":false,"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2022.12.009_bib0001","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/OPTH.S289359","article-title":"Current perspectives on corneal transplantation","volume":"16","author":"Liu","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2022.12.009_bib0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40135-022-00298-0","article-title":"Immunosuppressive therapy for high-risk corneal transplant","volume":"10","author":"Azam","year":"2022","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.jcjo.2022.12.009_bib0003","doi-asserted-by":"crossref","first-page":"e12559","DOI":"10.1111\/xen.12559","article-title":"Long-term survival of full-thickness corneal xenografts from \u03b11,3-galactosyltransferase gene-knockout miniature pigs in non-human primates","volume":"27","author":"Yoon","year":"2020","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.jcjo.2022.12.009_bib0004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/PL00007114","article-title":"[Immune suppression by combination therapy with basiliximab and cyclosporin in high risk keratoplasty: a pilot study]","volume":"99","author":"Schmitz","year":"2002","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jcjo.2022.12.009_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2008-1027129","article-title":"Basiliximab als Monotherapie nach perforierender Risikokeratoplastik-eine prospektive randomisierte Pilotstudie","volume":"225","author":"Birnbaum","year":"2008","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418222003945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418222003945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:24:22Z","timestamp":1762104262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418222003945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0008418222003945"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2022.12.009","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management of high-risk corneal transplantation using basiliximab and mycophenolate mofetil","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}